Osaka, Japan

Hiroshi Sugama

USPTO Granted Patents = 8 

 

 

Average Co-Inventor Count = 5.5

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Osaka-fu, JP (2015)
  • Osaka, JP (2009 - 2024)

Company Filing History:


Years Active: 2009-2024

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):

Title: Hiroshi Sugama: Innovator in Pharmaceutical Compounds

Introduction

Hiroshi Sugama is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, holding a total of 8 patents. His work primarily focuses on compounds that have therapeutic applications, particularly in the context of inhibiting NLRP3 inflammasome activity.

Latest Patents

Hiroshi Sugama's latest patents include innovative compounds and their uses. One notable patent relates to compounds of Formula (I) and their pharmaceutically acceptable salts. These compounds are designed to inhibit NLRP3 inflammasome activity, which may be beneficial in treating or preventing diseases associated with this inflammasome. Another significant patent involves a nitrogen-containing saturated heterocyclic compound that serves as a renin inhibitor. This compound is characterized by a specific formula that includes various functional groups, making it a valuable addition to therapeutic agents.

Career Highlights

Throughout his career, Hiroshi Sugama has worked with notable companies in the pharmaceutical industry. He has been associated with Mitsubishi Tanabe Pharma Corporation and Shanghai Pharmaceuticals Holding Co., Ltd. His work in these organizations has allowed him to develop and patent several important pharmaceutical compounds.

Collaborations

Hiroshi Sugama has collaborated with esteemed colleagues, including Toru Iijima and Jingkang Shen. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Hiroshi Sugama is a distinguished inventor whose work in pharmaceutical compounds has the potential to impact therapeutic practices significantly. His innovative patents and collaborations highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…